Propanc Biopharma SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KOct. 29, 2026, 5 p.m. ETView on SEC.gov Our explainer
Delisting notice / failure to meet listing standard
AI summary, unreviewedPropanc Biopharma Receives Nasdaq Delisting Notice for Failing $1.00 Minimum Bid Price, Will Appeal to Hearings Panel
S-1Oct. 5, 2026View on SEC.gov
10-KSept. 25, 2026, 5:08 p.m. ETView on SEC.gov